nivolumab
bms
['nadim ii', 'nadim', 'nsclc', 'lcsm,(-blcsm)', 'nivo', 'sclc']
nadim ii trials suggest nivo (i-o)+chemo as neoadj tx before surgery far superior than chemo alone, in pts w/ stage iiia nsclc &amp; who are good candidates for surgery. a new option for this group of patients. dr. mariano provencio-pulla #lcsm #asco22 
LUNGevity Foundation is dedicated to funding lung cancer research and providing support to ALL people affected by lung cancer.